瘤再辐射:放射生物学的问题,挑战和前景
Georges Noël1, Jolie Bou-Gharios2, Hélène Burckel2
1Radiotherapy Department, institut de cancérologie Strasbourg Europe (ICANS), 17, rue Albert-Calmette, BP 23025, 67033 Strasbourg, France; Faculté de médecine, université de Strasbourg, 4, rue Kirschleger, 67000 Strasbourg, France; Radiobiology Laboratory, institut de cancérologie Strasbourg Europe (ICANS), 17, rue Albert-Calmette, 67000 Strasbourg, France; Laboratory of Engineering, Informatics and Imaging (ICube), Integrative Multimodal Imaging in Healthcare (Imis), UMR 7357, université de Strasbourg, 4, rue Kirschleger, 67000 Strasbourg, France.
概括
了解瘤再辐射对于管理复发癌症至关重要. 需要进一步的研究来澄清组织辐射敏感性,并预测个性化放射治疗的并发症.
科学领域:
- 在瘤学瘤学.
- 辐射瘤学 辐射瘤学
- 放射生物学的放射生物学
背景情况:
- 对于复发性瘤的再辐射的放射生物学尚未得到充分理解.
- 有限的文献存在于组织辐射敏感度在初始照射后的变化.
- 评估瘤敏感性是有效控制病理的关键.
研究的目的:
- 为了探索瘤再辐射的放射生物学.
- 为了研究先前被辐射的组织的辐射敏感度的变化.
- 确定影响再辐射结果和并发症的因素.
主要方法:
- 关于瘤再辐射和组织放射敏感性的文献综述.
- 分析影响健康组织对辐射反应的因素.
- 讨论数学模型及其在预测结果方面的局限性.
主要成果:
- 目前对瘤再辐射放射生物学的理解是有限的,通常基于猜测.
- 健康组织的反应和放射性诱导并发症的可能性是严重的担忧.
- 健康组织的α/β比率是一个关键的,但往往未知的因素.
结论:
- 进一步的生物学研究对于了解初始照射后的组织耐受性和放射敏感性至关重要.
- 照射组织的基因组研究可以个性化放射治疗,并预测副作用.
- 优化再辐射策略需要对放射生物学的原理有更深入的了解.
相关概念视频
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Tumor Immunotherapy
491
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
491


